ingredient Crizotinib (250mg)
substitutes Crizocent 250mg 60s, Crizonix 250mg 28s,Xalkori 250mg 10s x 6 (IT)
treatment Non-small cell lung cancer
Shipping class Room Temperature
Medicine Overview by Anukar Pharmacy
( Crizalk 250mg 60 Capsule, Pfizer )
TreatmentCrizalk 250mg Capsule is used in the treatment of non-small cell lung cancer.
Side EffectsNausea, Vomiting, Edema (swelling), Diarrhoea, Constipation, Abdominal pain, Vision disorder, Dizziness, Altered taste, Fatigue, Decreased appetite, Rash, Decreased white blood cell count (neutrophils).
Method of UseTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Crizalk 250mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
How Crizalk 250mg 60 Capsule, Pfizer WorksCrizalk 250mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
More Info by Anukar Pharmacy
( Crizalk 250mg 60 Capsule, Pfizer )
Suggestions
- Inform your doctor before taking the medicine if you have lung problems, severe kidney disease, mild or moderate liver disease, reduced heart rate, abnormal ECG of heart, inflammation, perforation or cancer of the abdomen or intestines, or vision problems.
- Inform your doctor before taking the medicine for treatment of any infection, mental diseases, heart problems, migraine, gout, malaria, glaucoma, or cancer.
- You may be monitored for liver function, lung function test every month as crizotinib may cause life-threatening or fatal liver injury or inflammation of the lungs.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
- Do not drive or operate heavy machinery after taking this drug as it may cause dizziness, tiredness and problems with your vision.
Warning by Anukar Pharmacy
( Crizalk 250mg 60 Capsule, Pfizer )
Special precautions for Crizalk 250mg 60 Capsule, Pfizer Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
Interaction with alcohol is unknown. Please consult your doctor. | |
Pregnancy
|
WEIGH RISKS VS BENEFITS | Crizalk 250mg Capsule is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor. |
Lactation
|
caution | Crizalk 250mg Capsule is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby. |
Driving
|
Crizalk 250mg Capsule may make you feel dizzy, drowsy or affect your vision. Do not drive until your vision is clear. | |
Kidney
|
Crizalk 250mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Crizalk 250mg Capsule may be needed. Please consult your doctor. | |
Liver
|
caution | Crizalk 250mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Crizalk 250mg Capsule may be needed. Please consult your doctor. Use of Crizalk 250mg Capsule may not be advised in patients with the severe liver disease. |
Suggestion by Anukar Pharmacy on missing a dose
( Crizalk 250mg 60 Capsule, Pfizer )
If you miss a dose of Crizalk 250mg Capsule, skip it and continue with your normal schedule. Do not double the dose.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 克唑替尼, 克挫替尼, 赛可瑞 |
| 厂家 | 美国辉瑞 |
| 成分 | 主要成分克唑替尼 |
| 说明 |
克唑替尼,赛可瑞,CRIZALK,
克唑替尼（Crizotinib）是由美国辉瑞公司研制的抑制ALK/ROS1/Met的ATP竞争性的多靶点蛋白激酶抑制剂，分别在ALK、ROS1和MET激酶活性异常的肿瘤患者中证实对人体有显著临床疗效。Crizalk（crizotinib）是一种抗癌药物，会干扰癌细胞在体内的生长和扩散。Crizalk用于治疗已扩散到身体其他部位的非小细胞肺癌。
治疗作用：克唑替尼胶囊，用于治疗间变性淋巴瘤激酶(ALK)阳性的局部晚期和转移的非小细胞肺癌(NSCLC)。
|
* 以上中文信息由印度阿努卡药房收集的Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）中文网络信息和软件翻译获得，阿努卡药房认为Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）中文产品介绍信息存在与Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）实际数据不一致的可能。阿努卡药房请用户把Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）页面数据作为参考。印度阿努卡药房建议用户在实际使用Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）数据或者信息时，以Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）制造商公开发布的Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）商品信息为参考。使用方法，以用户医生建议使用Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）决定为参考。用户任何关于Crizalk 250mg 60 Capsule, Pfizer（克唑替尼, 克挫替尼, 赛可瑞）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
